{"id":200,"date":"2021-12-02T09:07:52","date_gmt":"2021-12-02T09:07:52","guid":{"rendered":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/?post_type=press-release&#038;p=200"},"modified":"2024-05-07T18:51:03","modified_gmt":"2024-05-07T18:51:03","slug":"ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors","status":"publish","type":"press-release","link":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\/","title":{"rendered":"ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors"},"content":{"rendered":"<p><strong>Barcelona, Spain, 2 December 2021:<\/strong> ONA Therapeutics (\u201cONA\u201d), which is focused on the discovery and development of therapeutic biologics targeting lipid metabolism to treat advanced cancer, today announces the appointment of Dr Michel Detheux as Independent Chair to its Board of Directors.<\/p>\n<p>Dr Michel Detheux is a veteran biotech executive with 25 years\u2019 experience within the industry. He is currently the President and CEO of iTeos Therapeutics (NASDAQ:ITOS), a clinical stage, publicly-traded biotech company developing novel immuno-oncology therapies focused on key mechanisms of immunosuppression. Dr Detheux has spearheaded several capital raises and transactions for iTeos, including an initial public offering on Nasdaq and strategic collaborations with Pfizer and GlaxoSmithKline.<\/p>\n<p>Dr Detheux studied at the Universit\u00e9 Catholique de Louvain, receiving his undergraduate degree and his PhD in biochemistry, before completing his post-doc at the University of Glasgow. Dr Detheux also holds a business certificate from Solvay Business School.<\/p>\n<p><strong>Valerie Vanhooren, Chief Executive Officer and Co-Founder of ONA Therapeutics said:<\/strong> <em>\u201cWe are thrilled to welcome Dr Michel Detheux as Independent Chair to the Board of Directors. Dr Detheux\u2019s expertise and outstanding track record will be invaluable to ONA as we advance our preclinical pipeline of novel therapies addressing the unmet medical need of patients with advanced cancer.\u201d<\/em><\/p>\n<p><strong>Dr Michel Detheux, Chair of ONA Therapeutics, said:<\/strong> <em>\u201cI am delighted to be joining ONA Therapeutics at this stage of the company\u2019s growth and progression. ONA has a unique combination of novel science, good investor base and bright talents to develop highly innovative therapeutics.\u201d<\/em><\/p>\n","protected":false},"template":"","class_list":["post-200","press-release","type-press-release","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ona Therapeutics | ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ona Therapeutics | ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors\" \/>\n<meta property=\"og:description\" content=\"Barcelona, Spain, 2 December 2021: ONA Therapeutics (\u201cONA\u201d), which is focused on the discovery and development of therapeutic biologics targeting lipid metabolism to treat advanced cancer, today announces the appointment of Dr Michel Detheux as Independent Chair to its Board of Directors. Dr Michel Detheux is a veteran biotech executive with 25 years\u2019 experience within [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Ona Therapeutics\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-07T18:51:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"968\" \/>\n\t<meta property=\"og:image:height\" content=\"440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@onatherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\\\/\",\"name\":\"Ona Therapeutics | ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#website\"},\"datePublished\":\"2021-12-02T09:07:52+00:00\",\"dateModified\":\"2024-05-07T18:51:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#website\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\",\"name\":\"Ona Therapeutics\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#organization\",\"name\":\"Ona Therapeutics\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/logo.png\",\"width\":968,\"height\":440,\"caption\":\"Ona Therapeutics\"},\"image\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/onatherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ona-therapeutics\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ona Therapeutics | ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Ona Therapeutics | ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors","og_description":"Barcelona, Spain, 2 December 2021: ONA Therapeutics (\u201cONA\u201d), which is focused on the discovery and development of therapeutic biologics targeting lipid metabolism to treat advanced cancer, today announces the appointment of Dr Michel Detheux as Independent Chair to its Board of Directors. Dr Michel Detheux is a veteran biotech executive with 25 years\u2019 experience within [&hellip;]","og_url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\/","og_site_name":"Ona Therapeutics","article_modified_time":"2024-05-07T18:51:03+00:00","og_image":[{"width":968,"height":440,"url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@onatherapeutics","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\/","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\/","name":"Ona Therapeutics | ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors","isPartOf":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#website"},"datePublished":"2021-12-02T09:07:52+00:00","dateModified":"2024-05-07T18:51:03+00:00","breadcrumb":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/"},{"@type":"ListItem","position":2,"name":"ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#website","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/","name":"Ona Therapeutics","description":"","publisher":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#organization","name":"Ona Therapeutics","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#\/schema\/logo\/image\/","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","contentUrl":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","width":968,"height":440,"caption":"Ona Therapeutics"},"image":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/onatherapeutics","https:\/\/www.linkedin.com\/company\/ona-therapeutics\/"]}]}},"_links":{"self":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/press-release\/200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/press-release"}],"about":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/types\/press-release"}],"wp:attachment":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/media?parent=200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}